The role of structured inpatient lipid protocols in optimizing non-statin lipid lowering therapy: a review and single-center experience

Chad Gier; Ian Gilchrist; Matthew Fordham; Luke Riordan; Ella Milchan; Nidhi Patel; Azad Mohedi; Sahana Choudhury; Tara Kits; Regina Cohen; Joseph Doughtery; John P. Reilly; Andreas Kalogeropoulos; Tahmid Rahman; On Chen

doi:10.3389/fcvm.2024.1284562

The role of structured inpatient lipid protocols in optimizing non-statin lipid lowering therapy: a review and single-center experience

Chad Gier
, Ian Gilchrist
, Matthew Fordham
, Luke Riordan
, Ella Milchan
, Nidhi Patel
, Azad Mohedi
, Sahana Choudhury
, Tara Kits
, Regina Cohen
, Joseph Doughtery
, John P. Reilly
, Andreas Kalogeropoulos
, Tahmid Rahman
, On Chen

Department of Medicine - Division of Cardiology

Stony Brook University

Research output: Contribution to journal › Short survey › peer-review

4 Scopus citations

Abstract

Dyslipidemia is a leading contributor to atherosclerotic cardiovascular disease (ASCVD). There has been a significant improvement in the treatment of dyslipidemia in the past 10 years with the development of new pharmacotherapies. The intent of this review is help enhance clinicians understanding of non-statin lipid lowering therapies in accordance with the 2022 American College of Cardiology Expert Consensus Clinical Decision Pathway on the Role of Non-statin Therapies for LDL-Cholesterol Lowering. We also present a single-center experience implementing a systematic inpatient protocol for lipid lowering therapy for secondary prevention of ASCVD.

Original language	English
Article number	1284562
Journal	Frontiers in Cardiovascular Medicine
Volume	11
DOIs	https://doi.org/10.3389/fcvm.2024.1284562
State	Published - 2024

Keywords

ASCVD
LDL—Cholesterol
hyperlipidemia
lipid lower medications
quality improvement

Access to Document

10.3389/fcvm.2024.1284562

Cite this

Gier, C., Gilchrist, I., Fordham, M., Riordan, L., Milchan, E., Patel, N., Mohedi, A., Choudhury, S., Kits, T., Cohen, R., Doughtery, J., Reilly, J. P., Kalogeropoulos, A., Rahman, T., & Chen, O. (2024). The role of structured inpatient lipid protocols in optimizing non-statin lipid lowering therapy: a review and single-center experience. Frontiers in Cardiovascular Medicine, 11, Article 1284562. https://doi.org/10.3389/fcvm.2024.1284562

@article{87e096004aff4d4fb2506e8ec9a7eb90,

title = "The role of structured inpatient lipid protocols in optimizing non-statin lipid lowering therapy: a review and single-center experience",

abstract = "Dyslipidemia is a leading contributor to atherosclerotic cardiovascular disease (ASCVD). There has been a significant improvement in the treatment of dyslipidemia in the past 10 years with the development of new pharmacotherapies. The intent of this review is help enhance clinicians understanding of non-statin lipid lowering therapies in accordance with the 2022 American College of Cardiology Expert Consensus Clinical Decision Pathway on the Role of Non-statin Therapies for LDL-Cholesterol Lowering. We also present a single-center experience implementing a systematic inpatient protocol for lipid lowering therapy for secondary prevention of ASCVD.",

keywords = "ASCVD, LDL{\textemdash}Cholesterol, hyperlipidemia, lipid lower medications, quality improvement",

author = "Chad Gier and Ian Gilchrist and Matthew Fordham and Luke Riordan and Ella Milchan and Nidhi Patel and Azad Mohedi and Sahana Choudhury and Tara Kits and Regina Cohen and Joseph Doughtery and Reilly, \{John P.\} and Andreas Kalogeropoulos and Tahmid Rahman and On Chen",

note = "Publisher Copyright: 2024 Gier, Gilchrist, Fordham, Riordan, Milchan, Patel, Mohedi, Choudhury, Kits, Cohen, Doughtery, Reilly, Kalogeropoulos, Rahman and Chen.",

year = "2024",

doi = "10.3389/fcvm.2024.1284562",

language = "English",

volume = "11",

journal = "Frontiers in Cardiovascular Medicine",

issn = "2297-055X",

}

Gier, C, Gilchrist, I, Fordham, M, Riordan, L, Milchan, E, Patel, N, Mohedi, A, Choudhury, S, Kits, T, Cohen, R, Doughtery, J, Reilly, JP , Kalogeropoulos, A , Rahman, T & Chen, O 2024, 'The role of structured inpatient lipid protocols in optimizing non-statin lipid lowering therapy: a review and single-center experience', Frontiers in Cardiovascular Medicine, vol. 11, 1284562. https://doi.org/10.3389/fcvm.2024.1284562

TY - JOUR

T1 - The role of structured inpatient lipid protocols in optimizing non-statin lipid lowering therapy

T2 - a review and single-center experience

AU - Gier, Chad

AU - Gilchrist, Ian

AU - Fordham, Matthew

AU - Riordan, Luke

AU - Milchan, Ella

AU - Patel, Nidhi

AU - Mohedi, Azad

AU - Choudhury, Sahana

AU - Kits, Tara

AU - Cohen, Regina

AU - Doughtery, Joseph

AU - Reilly, John P.

AU - Kalogeropoulos, Andreas

AU - Rahman, Tahmid

AU - Chen, On

N1 - Publisher Copyright: 2024 Gier, Gilchrist, Fordham, Riordan, Milchan, Patel, Mohedi, Choudhury, Kits, Cohen, Doughtery, Reilly, Kalogeropoulos, Rahman and Chen.

PY - 2024

Y1 - 2024

N2 - Dyslipidemia is a leading contributor to atherosclerotic cardiovascular disease (ASCVD). There has been a significant improvement in the treatment of dyslipidemia in the past 10 years with the development of new pharmacotherapies. The intent of this review is help enhance clinicians understanding of non-statin lipid lowering therapies in accordance with the 2022 American College of Cardiology Expert Consensus Clinical Decision Pathway on the Role of Non-statin Therapies for LDL-Cholesterol Lowering. We also present a single-center experience implementing a systematic inpatient protocol for lipid lowering therapy for secondary prevention of ASCVD.

AB - Dyslipidemia is a leading contributor to atherosclerotic cardiovascular disease (ASCVD). There has been a significant improvement in the treatment of dyslipidemia in the past 10 years with the development of new pharmacotherapies. The intent of this review is help enhance clinicians understanding of non-statin lipid lowering therapies in accordance with the 2022 American College of Cardiology Expert Consensus Clinical Decision Pathway on the Role of Non-statin Therapies for LDL-Cholesterol Lowering. We also present a single-center experience implementing a systematic inpatient protocol for lipid lowering therapy for secondary prevention of ASCVD.

KW - ASCVD

KW - LDL—Cholesterol

KW - hyperlipidemia

KW - lipid lower medications

KW - quality improvement

UR - https://www.scopus.com/pages/publications/85184480771

U2 - 10.3389/fcvm.2024.1284562

DO - 10.3389/fcvm.2024.1284562

M3 - Short survey

AN - SCOPUS:85184480771

SN - 2297-055X

VL - 11

JO - Frontiers in Cardiovascular Medicine

JF - Frontiers in Cardiovascular Medicine

M1 - 1284562

ER -

The role of structured inpatient lipid protocols in optimizing non-statin lipid lowering therapy: a review and single-center experience

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this